Dry eye syndrome (DES) is also known as keratisis sicca and kerato-conjunctivitis sicca. People suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface, which is made up of three intertwined layers, a superficial lipid layer, produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface.
Get More Information About : https://www.trendsmarketresearch.com/report/sample/3623
The two most common types of DES are DES associated with Sjogren syndrome (SS) and DES unassociated with SS. DES can also be classified as aqueous deficiency dry eye and evaporative dry eye disorder. According to TearScience Inc., in 2012, around 86% of the patients in Europe and the U.S. were suffering from DES showed symptoms of Meibomian Gland Dysfunction (MGD, blockage of meibomian glands). The blockage causes less secretion of oil in the tears, which results in evaporation of tears too quickly.
The global dry eye syndrome treatment market is primarily driven by growing geriatric population coupled with high prevalence of dry eye syndrome and growth in awareness about the diagnosis and treatment of the disease. However, the stringent drug approvals, expirations of the blockbuster drugs patents, and lack of skilled ophthalmologists are restraining the growth of DES market. According to National Health and Wellness Survey in 2013, approximately 16.4 million people are suffering from DES, which accounts for 6.8% of the total population of the U.S. Prevalence of DES increases with age, 2.7% for 18 – 34 age group and 18.6% for more than 75 age group were reported to be suffering from DES. The prevalence of DES is higher in women (8.8%) as compared to men (4.5%). According to the National Eye Institute, in the U.S the annual cost of treating DES including prescription drugs is US $ xx billion.
Global Dry Eye Syndrome Treatment Market: Segmentation
By Product Type
By Disease Type:
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
By Distribution Channel
High healthcare expenditure and increasing R&D activities in the DES treatment market is expected to propel growth of DES market in North America
Growing geriatric population coupled with high prevalence of dry eye syndrome owing to lifestyle disorders are contributing factors for the growth of DES market in the North America region.
Request For Table of Contents : https://www.trendsmarketresearch.com/report/requesttoc/3623
Asia Pacific region is emerging in DES treatment market due to large pool of patient population. According to the regional population based study published in All India Ophthalmological Society, in 2012, the prevalence of DES was 40.8% with mild symptoms and 31.7% with MGD.
Global dry eye syndrome treatment market is oligopolistic in nature with few players holding majority of the share. Various strategies are adopted by market players such as new product launches, acquisitions, and agreements in order to retain market position. In September, 2017, Johnson and Johnson Vision, acquired TearScience Inc., a medical device manufacturer for treating MGD. This acquisition expanded the company’s eye health portfolio. Allergan received marketing approval from FDA for its TrueTear Intranasal Tear Neurostimulator.
Some of the major players operating in the global dry eye syndrome treatment market are Allergan, Novartis AG., Otsuka Pharmaceutical Co. Ltd., Valent Pharmaceuticals, Johnson and Johnson Vision, Acadia Pharmaceuticals, Allostera Pharma, I-Med Pharma Inc., Santen Pharmaceuticals Co. Ltd., AFT pharmaceuticals, Novaliq GmBh, and Auven therapeutics.
Report Description: https://www.trendsmarketresearch.com/report/dry-eye-syndrome-treatment-market
View More : HEALTHCARE, PHARMACEUTICALS & MEDICAL DEVICES
Trends Market Research is one of the leading digital services provider and a result-oriented company based in U.K.. We are a team of enthusiastic-driven individuals with top notch skills in SEO , Market research. Trends Market Research is a one stop shop to all your business needs. We help you thrive and succeed. We provide research solution.
Our digital and enterprise research assurance solutions are ideal for Automotive & Transportation, Electronics & Semiconductor, Chemicals & Materials, Healthcare, Pharmaceuticals & Medical Devices, Food & Beverage and Industrial Automation as well as all type of other leading industries verticals . We offer a vast line of in-depth study of industry trends including customized & client oriented specific requirement.
One Vincent Square
Westminster, London SW1P 2PN